ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "psoriatic arthritis and ultrasonography"

  • Abstract Number: 652 • 2018 ACR/ARHP Annual Meeting

    Disease Interception in Psoriasis Patients with Subclinical Joint Inflammation By Interleukin 17 Inhibition with Secukinumab – Data from a Prospective Open Label Study

    Eleni Kampylafka1, Isabelle Oliveira1, Christina Linz2, Veronika Lerchen1, Matthias Englbrecht1, David Simon3, Michael Sticherling4, Juergen Rech5, Arnd Kleyer3, Georg Schett6 and Axel J. Hueber3, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, 2Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, e, Germany, 3Department of Internal Medicine 3—Rheumatology and Immunology, Friedrich-Alexander-University Erlangen–Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 4Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, 5Universitätsklinikum Erlangen, Erlangen, Germany, 6Department of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Musculoskeletal changes precede the onset of psoriatic arthritis (PsA). A subset of psoriasis patients is characterized by arthralgia as well as inflammatory changes in…
  • Abstract Number: 1208 • 2018 ACR/ARHP Annual Meeting

    Indicators for Active Musculoskeletal Ultrasound Findings of Psoriatic Arthritis Vary on Each Body Part

    Shuji Sumitomo1, Shoko Tateishi2, Yoko Soroida3, Harumi Shirai4, Tomomi Iwai5, Kuimiko Ono6, Jun Hirose6, Ayumi Yoshizaki7, Yoshihide Asano8, Shinichi Sato9, Sakae Tanaka6, Hitoshi Ikeda5, Keishi Fujio1, Kazuhiko Yamamoto10 and Hiroko Kanda11, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Immunotherapy Management, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, 3Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 4Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 5Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 6Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 7Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 8Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 9The University of Tokyo, Department of Dermatology, Tokyo, Japan, 10Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 11Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan

    Background/Purpose: Although some global composite measures (DAPSA, DAS28) reflect musculoskeletal ultrasound (MSUS) findings of psoriatic arthritis (PsA), there is little knowledge on how to predict…
  • Abstract Number: 882 • 2017 ACR/ARHP Annual Meeting

    A New Model of Care for Improving Early Rheumatology Access of Psoriatic Arthritis Patients

    Keith Colaco1,2, Dana Jerome3, Jensen Yeung4,5, Noah Ivers6,7,8, Carol Kitai7, Chandra Farrer3 and Lihi Eder1,9, 1Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, 2Institute of Medical Science, University of Toronto, Toronto, ON, Canada, 3Rheumatology, Women's College Hospital, Toronto, ON, Canada, 4Dermatology, Women's College Hospital, Toronto, ON, Canada, 5University of Toronto, Toronto, ON, Canada, 6Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 7Women's College Hospital, Toronto, ON, Canada, 8Family and Community Medicine, University of Toronto, Toronto, ON, Canada, 9Medicine, University of Toronto, Toronto, ON, Canada

    Background/Purpose: The prevalence of undiagnosed psoriatic arthritis (PsA) in psoriasis patients is high, with delays in diagnosis contributing to poor patient outcomes. We aimed to…
  • Abstract Number: 1551 • 2017 ACR/ARHP Annual Meeting

    Avoidance of Physical Activity Leads to Reduced Inflammatory Enthesitis on Ultrasound

    Kim Wervers1, Irene Herrings1, Jolanda J. Luime2, Marlies Moed1, Ilja Tchetverikov3, Andreas H. Gerards4, J.M.W. Hazes5 and Marijn Vis2, 1Erasmus Medical Centre, Rotterdam, Netherlands, 2Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands, 3Albert Schweitzer Hospital, Dordrecht, Netherlands, 4Sint Franciscus Vlietland Group, Schiedam, Netherlands, 5Department of Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands

    Background/Purpose: Enthesitis is one of the manifestations of psoriatic arthritis (PsA), but no clear definition for the diagnosis exists. To further evaluate the added value…
  • Abstract Number: 2883 • 2017 ACR/ARHP Annual Meeting

    Prevalence of Cardiovascular Risk Factors and Subclinical Cardovacular Disease in Psoriatic Arthritis

    María Paz Martínez-Vidal1, Cristina Fernández-Carballido2, Mariano Andres3, Vega Jovaní4, Carlos Santos5, Maria Nieves Martínez Alberola6, Francisca Sivera7 and Raquel Martin-domenech6, 1Rheumatology, Hospital general universitario de Alicante, Alicante, Spain, 2Hospital General Universitario de Elda, Elda, Spain, 3RHEUMATOLOGY, Hospital general universitario de Alicante, Alicante, Spain, 4Reumatología, Hospital general universitario de Alicante, Alicante, Spain, 5Rheumatology, Hospital de Alcoy, Alcoy, Spain, 6Rheumatology, Hospital General Universitario de Elda, Elda, Spain, 7Sección de Reumatología, Hospital General Universitario de Elda., Elda, Spain

    Background/Purpose: SCORE tables underestimate the Cardiovascular Risk (CVR) for patients with Rheumatoid Arthritis (RA) and EULAR recommends multiplying by 1.5 the CVR obtained from them…
  • Abstract Number: 960 • 2016 ACR/ARHP Annual Meeting

    Ultrasonographic Improvement of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated with Ustekinumab for Chronic Plaque Psoriasis: A 52-Week, Prospective, Open Label, Controlled Cohort Study

    Laura Savage1, Mark Goodfield2, Elizabeth M.A. Hensor3, Paul Emery3 and Dennis McGonagle4, 1NIHR Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Department of Dermatology, Leeds Centre for Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Subclinical enthesopathy is recognised in up to 50% of psoriasis patients and is thought to precede inflammatory PsA. It is not known if effective…
  • Abstract Number: 1696 • 2015 ACR/ARHP Annual Meeting

    Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients

    Maria Paz Martínez-Vidal1, Cristina Fernández-Carballido2, Francisca Sivera3, Raquel Martín-Doménech1, Nieves Martínez-Alberola1 and Alejandro San Martin4, 1Rheumatology, Hospital General Universitario Elda, ELDA, Spain, 2Rheumatology, Hospital General Universitario de Elda, Elda (Alicante), Spain, 3Reumatología, Hospital General Universitario de Elda, Alicante, Spain, 4Rheumatology, Univesity General Hospital, ELDA, Spain

    Background/Purpose: SCORE tables underestimate the Cardiovascular Risk (CVR) for patients with Rheumatoid Arthritis (RA) and EULAR recommends multiplying by 1.5 the CVR obtained from them…
  • Abstract Number: 1746 • 2015 ACR/ARHP Annual Meeting

    Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis

    Brigitte Michelsen1, Andreas P Diamantopoulos1,2, Hilde Berner Hammer3, Dag Magnar Soldal4, Arthur Kavanaugh5 and Glenn Haugeberg1,6,7, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, 5University of California, San Diego School of Medicine, LaJolla, CA, 6Rheumatology, Martina Hansens Hospital, Gjettum, Norway, 7Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway

    Background/Purpose: Coping may be defined as the set of adaptive processes a patient uses to live well with aspects of disease such as pain. Coping…
  • Abstract Number: 2614 • 2014 ACR/ARHP Annual Meeting

    Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments

    Agnes Szentpetery1, Muhammad Haroon2, Eileen O'Flynn1, Phil Gallagher1, Shafeeq Alraqi1 and Oliver FitzGerald1, 1Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, 2Newmarket On Fergus, Cork University Hospital, Cork, Ireland

    Background/Purpose 68 tender (TJC) and 66 swollen joint counts (SJC) are recommended for disease activity assessment in psoriatic arthritis (PsA).  However there are time constraints…
  • Abstract Number: 2503 • 2013 ACR/ARHP Annual Meeting

    IL-17+ CD8+ T Cells Are Enriched In The Joints Of Patients With Psoriatic Arthritis and Correlate With Markers Of Disease Activity and Joint Damage Progression

    Bina Menon1,2, Nicola J. Gullick3, Hayley G. Evans4, Gina J. Walter4, Megha Rajasekhar4, Toby Garrood2, Leonie S. Taams4 and Bruce W. Kirkham2, 1Centre for Cellular and Molecular Biology of Inflammation, King's College London, London, United Kingdom, 2Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, 3Rheumatology, King's College Hospital Foundation NHS Trust, London, United Kingdom, 4Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, United Kingdom

    Background/Purpose: Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) have clear differences in clinical, radiological and genetic features, suggesting that the immunopathology of the conditions may…
  • Abstract Number: 1111 • 2013 ACR/ARHP Annual Meeting

    Utility Of An Ultrasound Enthesitis Score As a Complementary Diagnostic Tool To Detect Psoriatic Arthritis In Patients With Psoriasis

    Tomas Cazenave1, Christian A. Waimann2, Gustavo Citera1 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: To evaluate the prevalence of subclinical enthesopathy in psoriasis (Ps) patients compared with psoriatic arthritis (PsA) and healthy controls (HC), and to assess the…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology